| Troxerutin affects nephropathy signaling events in the kidney of type-1 diabetic male rats
Objective: Nephropathy is known to be the leading cause of
kidney failure in diabetic patients. Troxerutin, as a flavonoid
component, could provide a novel protective strategy in the
prevention of diabetic nephropathy. A large number of reports on
the salutary effects of troxerutin inspired us to investigate its effect
on the nephropathy signaling events (i.e., expression of TGF-β,
miRNA192, and SIP1) in type-1 induced diabetic rats.
Materials and Methods: 50 male Wistar rats were divided into 5
groups including control group, sham group treated with troxerutin
for 4 weeks, diabetic group induced by streptozotocin (STZ)
injection, DI group including insulin-treated diabetic animals and
DT group treated with troxerutin. Ultimately, rat kidneys were
extracted, and the level of miR-192 (using qPCR), transforming
growth factor-beta (TGF-β), and smad interacting protein 1 (SIP1)
using an ELISA kit, was measured.
Results: The level of TGF-β and miRNA192 significantly
increased in the diabetic group. However, their expression levels
decreased following the administration of troxerutin and insulin
(p<0.05) compared to control group. SIP1 was down-regulated in
the diabetic group, whereas a spike in the expression levels was
observed after troxerutin administration compared to control and
troxerutin groups (p<0.05). However, no significant difference
was found in the effects of insulin and troxerutin on the level of
miR-192, SIP1, and TGF- β.
Conclusion: According to the previous literatures, during the
progression of nephropathy, TGF-β represses SIP1 (the repression
region in the collagen gene) by increasing the expression of miR192. Ultimately, in this study, diabetes led to up-regulation of
TGF-β while troxerutin proved to have a protective effect on the
kidney by increasing SIP and lowering miR-192 levels. |